Crossmark

The controversy around anti-amyloid antibodies for treating Alzheimer’s disease

Published Online: 2024-10-23

Authors

Hunter, Philip
License Information

Text and Data Mining valid from 2024-10-23

Version of Record valid from 2024-10-23
More Information

Article History

Received: 9 October 2024

Accepted: 14 October 2024

First Online: 23 October 2024

Disclosure and competing interests statement

: The author declares no competing interests.

Document is current